CN114146041A - 一种胶原针自体修复医用面膜及其制备方法 - Google Patents
一种胶原针自体修复医用面膜及其制备方法 Download PDFInfo
- Publication number
- CN114146041A CN114146041A CN202111599174.0A CN202111599174A CN114146041A CN 114146041 A CN114146041 A CN 114146041A CN 202111599174 A CN202111599174 A CN 202111599174A CN 114146041 A CN114146041 A CN 114146041A
- Authority
- CN
- China
- Prior art keywords
- preparation
- collagen
- mask
- skin
- repairing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 33
- 108010035532 Collagen Proteins 0.000 title claims abstract description 33
- 229920001436 collagen Polymers 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241001116389 Aloe Species 0.000 claims abstract description 16
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 241000219357 Cactaceae Species 0.000 claims abstract description 15
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims abstract description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 7
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 7
- 241000207929 Scutellaria Species 0.000 claims abstract description 7
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 7
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 7
- 229960000458 allantoin Drugs 0.000 claims abstract description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960001631 carbomer Drugs 0.000 claims abstract description 7
- 229940106189 ceramide Drugs 0.000 claims abstract description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000905 isomalt Substances 0.000 claims abstract description 7
- 235000010439 isomalt Nutrition 0.000 claims abstract description 7
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000787 lecithin Substances 0.000 claims abstract description 7
- 229940067606 lecithin Drugs 0.000 claims abstract description 7
- 235000010445 lecithin Nutrition 0.000 claims abstract description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920000136 polysorbate Polymers 0.000 claims abstract description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 7
- 229940068965 polysorbates Drugs 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 25
- 238000004806 packaging method and process Methods 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 14
- 230000001815 facial effect Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000007789 sealing Methods 0.000 claims description 9
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 8
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 8
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000011550 stock solution Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 239000002390 adhesive tape Substances 0.000 claims description 3
- 230000003749 cleanliness Effects 0.000 claims description 3
- 229960005188 collagen Drugs 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229950008882 polysorbate Drugs 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 238000012372 quality testing Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000035876 healing Effects 0.000 abstract description 6
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 206010072170 Skin wound Diseases 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000010261 cell growth Effects 0.000 abstract description 3
- 239000003102 growth factor Substances 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 238000001556 precipitation Methods 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000008591 skin barrier function Effects 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 2
- 239000000049 pigment Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 230000003796 beauty Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000008439 repair process Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- -1 flavonoid compounds Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009013 pigment accumulation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种胶原针自体修复医用面膜及其制备方法，涉及医疗美容技术领域，包括以下原材料：水15‑18％、甘油7‑8％、卵磷脂5‑8％、丙二醇3‑4％、生物糖胶7‑8％、尿囊素6‑6.5％、异麦芽5‑6％、聚山梨醇脂3.5‑4％、麦冬4.5‑5％、光果甘草根6‑7％、仙人掌5‑5.5％、芦荟4‑5％、黄芩根2.5‑3％、卡波姆3‑4％、丁二醇1.5‑2％、可溶性胶原8‑9％、神经酰胺6.5‑7％、透明质酸钠2.5‑3％。该胶原针自体修复医用面膜及其制备方法，通过补水抗氧化，使得细胞的增殖和再生能力得到提升，在肌肤表面形成一透气、清爽的保湿层，从而与细胞生长因子活性成分协同作用，促进皮肤伤口愈合，缩短皮肤愈合过程，加快皮肤屏障的修复，减轻炎症后色素积累沉淀，提高皮肤弹性，使皮肤快速恢复健康状态。
Description
技术领域
本发明涉及医疗美容技术领域，具体为一种胶原针自体修复医用面膜及其制备方法。
背景技术
随着人民生活水平的不断提高和广大人民群众对医疗保健需求的不断增加，医疗整形美容行业也得到了不断发展，每年有几十万人接受各类医疗整形美容手术，医疗美容，是指运用药物、手术、医疗器械以及其他具有创伤性或者不可逆性的医学技术方法对人的容貌和人体各部位形态进行的修复与再塑的美容方式，医疗美容过程中肌肤十分脆弱，不适宜使用成分复杂，安全性、亲肤性差的普通化妆品，需要使用医用面膜进行皮肤修复工作。
现有的胶原针自体修复医用面膜，存在只能对浅层的皮肤进行修复，需要配合医用药物才能达到皮肤深层修复的效果，实际使用效果较差的问题，为此，我们提出这样一种胶原针自体修复医用面膜及其制备方法。
发明内容
针对现有技术的不足，本发明提供了一种胶原针自体修复医用面膜及其制备方法，解决了上述背景技术中提出的问题。
为实现以上目的，本发明通过以下技术方案予以实现，一种胶原针自体修复医用面膜，包括以下原材料：水15-18％、甘油7-8％、卵磷脂5-8％、丙二醇3-4％、生物糖胶7-8％、尿囊素6-6.5％、异麦芽5-6％、聚山梨醇脂3.5-4％、麦冬4.5-5％、光果甘草根6-7％、仙人掌5-5.5％、芦荟4-5％、黄芩根2.5-3％、卡波姆3-4％、丁二醇1.5-2％、可溶性胶原8-9％、神经酰胺6.5-7％、透明质酸钠2.5-3％。
可选的，所述胶原针自体修复医用面膜制备方法包括以下步骤：
S1、选材去杂；
S2、粉碎混合；
S3、加热混合；
S4、检验灭菌；
S5、成品包装。
可选的，所述胶原针自体修复医用面膜制备方法包括以下具体步骤：
S1、选材去杂
选取一定的比例麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行清理去杂，然后对去杂的麦冬、光果甘草根、仙人掌、芦荟及黄芩根清理及烘干，进行备用，保证原料的洁净度；
S2、粉碎混合
将清理完成的麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行破碎、离心及过滤，得到相对应原料的提取液，然后一次加入混合机中进行混合搅拌，得到混合原液；
S3、加热混合
将水水、甘油、卵磷脂、丙二醇、生物糖胶、尿囊素、异麦芽及聚山梨醇脂加入配置锅中，将配置锅加热至45℃，进行加热搅拌使得充分融合，然后将温度提升至85℃，加入步骤S1中所得到的混合原液，再次进行加热搅拌相融合，最后降温至5045℃，依次加入卡波姆、丁二醇、可溶性胶原、神经酰胺及透明质酸钠进行搅拌混合，最终得到面膜溶液；
S4、检验灭菌
等待面膜溶液温度降至常温时，质检人员按照单批量的面膜溶液进行一定量的抽检、抽检成分配比合格后对面膜溶液进行统一灭菌；
S5、成品包装
将合格的面膜溶液抽至装有面膜布的包装袋进行装袋，每袋30ml，每10分钟进行随机抽取检查，检查批号、装量和密封，然后按包装规格要求包装，并放入1张说明书，盖上盒盖，贴封口签，用胶带封箱，再用打包机打包入库。
可选的，所述步骤S1选材去杂过程中麦冬、光果甘草根、仙人掌、芦荟及黄芩根的烘干温度为45-55℃。
可选的，所述步骤S2粉碎混合过程中混合机的转速为700-850r/min。
可选的，所述步骤S4检验灭菌过程中抽检量为单批量的25％。
本发明提供了一种胶原针自体修复医用面膜及其制备方法，具备以下有益效果：该胶原针自体修复医用面膜，通过补水抗氧化，使得细胞的增殖和再生能力得到提升，可以对医疗美容过程中受损肌肤表面形成一透气、清爽的保湿层，从而与细胞生长因子活性成分协同作用，促进皮肤伤口愈合，缩短皮肤愈合过程，加快皮肤屏障的修复，同时减轻炎症后色素积累沉淀，恢复并提高皮肤弹性，使皮肤快速恢复健康状态，并且具有很好的燥湿、清热，尤善清中上焦湿热，亦有较强的泻火解毒，凉血止血功效，同时含有的黄酮类化合物能吸收紫外线，清除氧自由基，又能抑制黑色素的产生，具有抗衰老、美白、祛斑的效果，可以保护真皮层细胞，改善血液循环，防止细胞被氧化产生皱纹，能够提高肌肤明亮度，让肌肤呈现年轻水润的健康状态，使肌肤焕发年轻光彩，能够解决综合性皮肤衰老问题，通过提高机体抗氧化能力，清除衰老机体产生的过多自由基，抑制机体组织、细胞的过氧化过程，使机体的各项生命体征得到改善，而起到了延缓衰老的作用。
具体实施方式
下面将结合本发明的具体实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。
一种胶原针自体修复医用面膜，包括以下原材料：水15-18％、甘油7-8％、卵磷脂5-8％、丙二醇3-4％、生物糖胶7-8％、尿囊素6-6.5％、异麦芽5-6％、聚山梨醇脂3.5-4％、麦冬4.5-5％、光果甘草根6-7％、仙人掌5-5.5％、芦荟4-5％、黄芩根2.5-3％、卡波姆3-4％、丁二醇1.5-2％、可溶性胶原8-9％、神经酰胺6.5-7％、透明质酸钠2.5-3％。
胶原针自体修复医用面膜制备方法包括以下具体步骤：
S1、选材去杂：选取一定的比例麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行清理去杂，然后对去杂的麦冬、光果甘草根、仙人掌、芦荟及黄芩根清理及烘干，进行备用，保证原料的洁净度；
选材去杂过程中麦冬、光果甘草根、仙人掌、芦荟及黄芩根的烘干温度为45-55℃；
S2、粉碎混合：将清理完成的麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行破碎、离心及过滤，得到相对应原料的提取液，然后一次加入混合机中进行混合搅拌，得到混合原液；
粉碎混合过程中混合机的转速为700-850r/min；
S3、加热混合：将水水、甘油、卵磷脂、丙二醇、生物糖胶、尿囊素、异麦芽及聚山梨醇脂加入配置锅中，将配置锅加热至45℃，进行加热搅拌使得充分融合，然后将温度提升至85℃，加入步骤S1中所得到的混合原液，再次进行加热搅拌相融合，最后降温至5045℃，依次加入卡波姆、丁二醇、可溶性胶原、神经酰胺及透明质酸钠进行搅拌混合，最终得到面膜溶液；
S4、检验灭菌：等待面膜溶液温度降至常温时，质检人员按照单批量的面膜溶液进行一定量的抽检、抽检成分配比合格后对面膜溶液进行统一灭菌；
检验灭菌过程中抽检量为单批量的25％；
S5、成品包装：将合格的面膜溶液抽至装有面膜布的包装袋进行装袋，每袋30ml，每10分钟进行随机抽取检查，检查批号、装量和密封，然后按包装规格要求包装，并放入1张说明书，盖上盒盖，贴封口签，用胶带封箱，再用打包机打包入库。
本发明提供了一种绿色环保免喷涂类肤材料及其制备方法，具备以下有益效果：
该胶原针自体修复医用面膜，通过补水抗氧化，使得细胞的增殖和再生能力得到提升，在肌肤表面形成一透气、清爽的保湿层，从而与细胞生长因子活性成分协同作用，促进皮肤伤口愈合，缩短皮肤愈合过程，加快皮肤屏障的修复，同时减轻炎症后色素积累沉淀，恢复并提高皮肤弹性，使皮肤快速恢复健康状态，并且具有很好的燥湿、清热，尤善清中上焦湿热，亦有较强的泻火解毒，凉血止血功效，同时含有的黄酮类化合物能吸收紫外线，清除氧自由基，又能抑制黑色素的产生，具有抗衰老、美白、祛斑的效果，可以保护真皮层细胞，改善血液循环，防止细胞被氧化产生皱纹，能够提高肌肤明亮度，让肌肤呈现年轻水润的健康状态，使肌肤焕发年轻光彩，能够解决综合性皮肤衰老问题，通过提高机体抗氧化能力，清除衰老机体产生的过多自由基，抑制机体组织、细胞的过氧化过程，使机体的各项生命体征得到改善，而起到了延缓衰老的作用。
该胶原针自体修复医用面膜使用步骤如下：
1.展开面膜；
2.以眼部和嘴部为基准，将面膜敷于脸部并用手指
轻轻抚平，直至面膜完整贴合于脸部；
3.静享15分钟面膜修护补水
4.轻轻取下面膜，轻拍脸部直至精华全部吸收。
Claims (6)
1.一种胶原针自体修复医用面膜，其特征在于，包括以下原材料：水15-18％、甘油7-8％、卵磷脂5-8％、丙二醇3-4％、生物糖胶7-8％、尿囊素6-6.5％、异麦芽5-6％、聚山梨醇脂3.5-4％、麦冬4.5-5％、光果甘草根6-7％、仙人掌5-5.5％、芦荟4-5％、黄芩根2.5-3％、卡波姆3-4％、丁二醇1.5-2％、可溶性胶原8-9％、神经酰胺6.5-7％、透明质酸钠2.5-3％。
2.根据权利要求1所述的一种胶原针自体修复医用面膜，其特征在于，所述胶原针自体修复医用面膜制备方法包括以下步骤：
S1、选材去杂；
S2、粉碎混合；
S3、加热混合；
S4、检验灭菌；
S5、成品包装。
3.根据权利要求1-2任一项所述的一种胶原针自体修复医用面膜，其特征在于，所述胶原针自体修复医用面膜制备方法的制备方法包括以下具体步骤：
S1、选材去杂
选取一定的比例麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行清理去杂，然后对去杂的麦冬、光果甘草根、仙人掌、芦荟及黄芩根清理及烘干，进行备用，保证原料的洁净度；
S2、粉碎混合
将清理完成的麦冬、光果甘草根、仙人掌、芦荟及黄芩根进行破碎、离心及过滤，得到相对应原料的提取液，然后一次加入混合机中进行混合搅拌，得到混合原液；
S3、加热混合
将水水、甘油、卵磷脂、丙二醇、生物糖胶、尿囊素、异麦芽及聚山梨醇脂加入配置锅中，将配置锅加热至45℃，进行加热搅拌使得充分融合，然后将温度提升至85℃，加入步骤S1中所得到的混合原液，再次进行加热搅拌相融合，最后降温至5045℃，依次加入卡波姆、丁二醇、可溶性胶原、神经酰胺及透明质酸钠进行搅拌混合，最终得到面膜溶液；
S4、检验灭菌
等待面膜溶液温度降至常温时，质检人员按照单批量的面膜溶液进行一定量的抽检、抽检成分配比合格后对面膜溶液进行统一灭菌；
S5、成品包装
将合格的面膜溶液抽至装有面膜布的包装袋进行装袋，每袋30ml，每10分钟进行随机抽取检查，检查批号、装量和密封，然后按包装规格要求包装，并放入1张说明书，盖上盒盖，贴封口签，用胶带封箱，再用打包机打包入库。
4.根据权利要求3所述的一种胶原针自体修复医用面膜制备方法，其特征在于：所述步骤S1选材去杂过程中麦冬、光果甘草根、仙人掌、芦荟及黄芩根的烘干温度为45-55℃。
5.根据权利要求3所述的一种胶原针自体修复医用面膜制备方法，其特征在于：所述步骤S2粉碎混合过程中混合机的转速为700-850r/min。
6.根据权利要求3所述的一种胶原针自体修复医用面膜制备方法，其特征在于：所述步骤S4检验灭菌过程中抽检量为单批量的25％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111599174.0A CN114146041A (zh) | 2021-12-24 | 2021-12-24 | 一种胶原针自体修复医用面膜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111599174.0A CN114146041A (zh) | 2021-12-24 | 2021-12-24 | 一种胶原针自体修复医用面膜及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114146041A true CN114146041A (zh) | 2022-03-08 |
Family
ID=80452207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111599174.0A Pending CN114146041A (zh) | 2021-12-24 | 2021-12-24 | 一种胶原针自体修复医用面膜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114146041A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109806211A (zh) * | 2019-03-15 | 2019-05-28 | 江苏煦音生物科技有限公司 | 一种肌肤修护面膜及其制备方法 |
| CN113069383A (zh) * | 2021-04-09 | 2021-07-06 | 北京美啦美健康管理有限公司 | 一种胶原针自体修复医用面膜及其制备方法 |
-
2021
- 2021-12-24 CN CN202111599174.0A patent/CN114146041A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109806211A (zh) * | 2019-03-15 | 2019-05-28 | 江苏煦音生物科技有限公司 | 一种肌肤修护面膜及其制备方法 |
| CN113069383A (zh) * | 2021-04-09 | 2021-07-06 | 北京美啦美健康管理有限公司 | 一种胶原针自体修复医用面膜及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104523490B (zh) | 一种具有美白保湿功效的去角质组合物及其制备方法 | |
| CN104173251B (zh) | 一种牦牛骨胶原肽美白面膜及其制备方法 | |
| CN104887609B (zh) | 一种保湿面膜液及其制备方法 | |
| CN111529417B (zh) | 一种具有抗蓝光功效修护眼霜及其制备方法 | |
| CN110664650A (zh) | 多效护肤组合物和精华液及其制备方法 | |
| CN113318058A (zh) | 胶原蛋白补充剂、射频美容用自体胶原蛋白液及其使用方法和应用 | |
| CN113786376B (zh) | 一种具有去眼纹功效的眼霜组合物及其制备方法 | |
| CN106606452A (zh) | 一种调整水油平衡和美白的精华液 | |
| CN103083214A (zh) | 一种芦荟保湿液及应用 | |
| CN109260116A (zh) | 一种含有植物提取物的至肽肌底液及其生产工艺 | |
| CN111012733B (zh) | 一种豆腐柴乳酸敷面剂 | |
| CN107095835A (zh) | 一种野山参干细胞乳状面膜及制备方法 | |
| CN114146041A (zh) | 一种胶原针自体修复医用面膜及其制备方法 | |
| CN113171324A (zh) | 一种苹果肌丝滑面膜及其制备方法 | |
| CN110859758A (zh) | 一种美白抗衰老修复型医用冷敷贴及其制备方法 | |
| CN112370411A (zh) | 一种美白修护精华液及其制备方法 | |
| CN112120956A (zh) | 一种修复受损肌肤的多肽组合物 | |
| CN106983703A (zh) | 一种修复激素损伤皮肤的化妆品组合物及其制备方法和应用 | |
| WO2018082117A1 (zh) | 具有祛除皮肤红血丝功能的外用中药组合物及其护肤制剂 | |
| CN108113916B (zh) | 一种天然修复肽面膜液及其制备方法 | |
| KR102407129B1 (ko) | 피부 타입 맞춤형 스크럽 즉석 제조 방법 | |
| CN108619018B (zh) | 一种皮肤屏障修复霜及其制备方法 | |
| CN112587468A (zh) | 一种多功能多效合一眼霜 | |
| CN107875097A (zh) | 一种紧肤祛皱面膜及制备方法 | |
| CN102462655A (zh) | 一种中草药抗皱美容膏及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220308 |